WATERTOWN, Mass.--(BUSINESS WIRE)--Feb. 7, 2006--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, announced today that the Company will report its fourth quarter and full year 2005 financial results after the U.S. Financial Markets close on Tuesday, February 14, 2006. Following the announcement, Panacos will hold a conference call to discuss the results and provide an update on the Company’s development programs. Dr. Samuel K. Ackerman, President and CEO, will lead the call.
